Fueling Growth in AI-Powered HealthTech
UAE-based Valeo Health, a leader in AI-driven healthcare, has successfully raised $12 million in a Series B funding round, bringing its total investment to $20 million. This round was led by Flintera, with participation from existing investors Nuwa Capital, FJ Labs, Oryx, and Mindshift Capital, alongside new investors like Oraseya and Eirad.
Co-founded in 2021 by Sundeep Sahni, Nadine Karadag, and Ankur Majumder, Valeo Health is reshaping personalized, data-driven healthcare. With this new investment, the company aims to expand its reach across Saudi Arabia, UAE, and wider GCC region. This helps in making its science-backed healthcare solutions more accessible than ever.
Scaling AI-Powered Preventive Care
Valeo Health has been at the forefront of AI-powered home healthcare. It is offering personalized treatment plans and proprietary Longevity technology. These treatments empower individuals to take control of their well-being. This latest funding reflects growing confidence in the company’s ability to redefine preventive healthcare. And, in effect, bringing cutting-edge innovation to the region.
“We are thrilled by the strong investor support as we continue to redefine how people engage with their health,” said Sundeep Sahni, CEO & Co-Founder of Valeo Health. “This funding enables us to scale our AI technology, enhance our product offerings, and expand our reach, ensuring more individuals benefit from proactive healthcare solutions.”
Co-founder Nadine Karadag added, “This investment validates our team’s hard work and strengthens our ability to scale personalized healthcare across the region.”
Investor Confidence in Valeo’s Vision
Flintera, the lead investor, sees Valeo Health as a game-changer in the region’s healthcare landscape. “Valeo is not just another health-tech platform — it’s shaping the future of preventive care in the region,” said a Flintera representative. “At Flintera, we back founders who merge cutting-edge technology with a scalable vision. Therefore, Sundeep and his team embody exactly that.”
Similarly, Nitin Reen, Partner at Nuwa Capital, emphasized Valeo’s impressive growth trajectory and customer-focused approach. “We first backed Valeo in 2021, recognizing the strength of its founding team and its potential to address a real market need. Since then, they have built an integrated platform with strong cross-border potential, showing year-over-year growth. With this round, Valeo can further deepen its customer engagement and expand its offerings.”
Pioneering the Future of Personalized Healthcare
As a trusted name in health-tech across KSA and UAE, Valeo Health aims to providing real-time health insights. Along with personalized wellness solutions, and AI-driven healthcare advancements. With this new investment, the company is striving to scale operations, drive innovation, and transform healthcare accessibility in the GCC.
By blending technology, data, and proactive health solutions, Valeo Health is reshaping the future of preventive healthcare, helping individuals lead healthier, longer lives.